Literature DB >> 16540764

Genetic influences in nonalcoholic fatty liver disease.

Raphael B Merriman1, Bradley E Aouizerat, Nathan M Bass.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a metabolic liver disease with widely variable phenotypes extending from simple steatosis, through nonalcoholic steatohepatitis (NASH) to cirrhosis and hepatocellular carcinoma. Inevitably, this reflects the interplay of well-recognized environmental factors and disease associations such as obesity and insulin resistance with host genetic factors, which are polygenic or complex in nature. Most of the observed phenotypic variability will probably be explained by variations in single nucleotide polymorphism frequency, although knowledge of the effect of most polymorphisms on biologic function is currently limited. Several observational studies of kindred with NASH suggest a genetic contribution. Most data characterizing genetic variation in different NAFLD phenotypes is derived from case-control association studies involving putative candidate genes. These candidate genes have been selected largely based upon the "two-hit hypothesis" of the pathogenesis of NAFLD, although other hypothesis-independent approaches can also be informative in gene selection. Thus far, candidate gene association studies have had significant limitations such as small cohort sizes and poor reproducibility. Rapid technologic developments are increasing the capability of detecting genetic variation. Identification of the genetic contribution to NAFLD will inform theories of disease pathogenesis and progression and ultimately improve management.

Entities:  

Mesh:

Year:  2006        PMID: 16540764     DOI: 10.1097/01.mcg.0000168643.16074.19

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  19 in total

1.  Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Gustavo Castaño; Carolina Gemma; Tomas-Fernández Gianotti; Carlos-Jose Pirola
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

Review 2.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

3.  Non-alcoholic steatohepatitis over multiple generations.

Authors:  Christine Carter-Kent; Ariel E Feldstein
Journal:  Dig Dis Sci       Date:  2009-07-23       Impact factor: 3.199

4.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.

Authors:  Rohit Loomba; Maria Abraham; Aynur Unalp; Laura Wilson; Joel Lavine; Ed Doo; Nathan M Bass
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

5.  Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats.

Authors:  XinXia Chang; HongMei Yan; Jing Fei; MingHong Jiang; HongGuang Zhu; DaRu Lu; Xin Gao
Journal:  J Lipid Res       Date:  2010-06-21       Impact factor: 5.922

Review 6.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

7.  A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes.

Authors:  Ignazio Grattagliano; Catia V Diogo; Maria Mastrodonato; Ornella de Bari; Michele Persichella; David Q H Wang; Adriana Liquori; Domenico Ferri; Maria Rosaria Carratù; Paulo J Oliveira; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

8.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease.

Authors:  Xiaohua Yan; Liyun Xu; Jianni Qi; Xiaohong Liang; Chunhong Ma; Chun Guo; Lining Zhang; Wensheng Sun; Jiyun Zhang; Xiaoyi Wei; Lifen Gao
Journal:  Immunogenetics       Date:  2009-07-23       Impact factor: 2.846

9.  Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet.

Authors:  Igor P Pogribny; Volodymyr P Tryndyak; Tetyana V Bagnyukova; Stepan Melnyk; Beverly Montgomery; Sharon A Ross; John R Latendresse; Ivan Rusyn; Frederick A Beland
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

10.  Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.

Authors:  Rohit Loomba; Shih-Jen Hwang; Christopher J O'Donnell; R Curtis Ellison; Ramachandran S Vasan; Ralph B D'Agostino; T Jake Liang; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.